Transient inhibition of astrocytogenesis in developing mouse brain following postnatal caffeine exposure

Pediatric Research

Volumn 62, Issue 5, 2007, Pages 604-609

  Desfrere, Luc ^a,b,c   Olivier, Paul ^a,b   Schwendimann, Leslie ^a   Verney, Catherine ^b   Gressens, Pierre ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Université Paris 5 René Descartes ^*  (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR; BROXURIDINE; CAFFEINE; CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN P15; PROTEIN S100B; SYNAPTOPHYSIN; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE; ADENOSINE A2A RECEPTOR; DRUG DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN; MTAP2 PROTEIN, MOUSE; NERVE GROWTH FACTOR; PHENETHYLAMINE DERIVATIVE; PROTEIN S 100; PYRIMIDINE DERIVATIVE; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; ENZYME DEGRADATION; GLIA CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBVENTRICULAR ZONE; ANIMAL; ANIMAL BEHAVIOR; ANIMAL MODEL; ASTROCYTE; BODY WEIGHT; BRAIN; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; NEWBORN; ORGAN SIZE; TIME;

ADENOSINE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CAFFEINE; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, ANIMAL; NERVE GROWTH FACTORS; ORGAN SIZE; PHENETHYLAMINES; PYRIMIDINES; RECEPTOR, ADENOSINE A2A; S100 PROTEINS; SYNAPTOPHYSIN; TIME FACTORS; TRIAZOLES;

EID: 38849145875     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318156e425     Document Type: Article

References (35)

1. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W 2006 Caffeine therapy for apnea of prematurity. N Engl J Med 354:2112-2121
2. Nehlig A, Daval JL, Debry G 1992 Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 17:139-170
3. Brazier JL, Ritter J, Berland M, Khenfer D, Faucon G 1983 Pharmacokinetics of caffeine during and after pregnancy. Dev Pharmacol Ther 6:315-322
4. Wilkinson JM, Pollard I 1993 Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine. Brain Res Dev Brain Res 75:193-199
5. Sahir N, Bahi N, Evrard P, Gressens P 2000 Caffeine induces in vivo premature appearance of telencephalic vesicles. Brain Res Dev Brain Res 121:213-217
6. Concannon JT, Braughler JM, Schechter MD 1983 Pre- and postnatal effects of caffeine on brain biogenic amines, cyclic nucleotides and behavior in developing rats. J Pharmacol Exp Ther 226:673-679
7. Kang SH, Lee YA, Won SJ, Rhee KH, Gwag BJ 2002 Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures. Neuroreport 13:1945-1950
8. Allan WC, Volpe JJ 1979 Reduction of cholesterol synthesis by methylxanthines in cultured glial cells. Pediatr Res 13:1121-1124
9. Marret S, Delpech B, Girard N, Leroy A, Maingonnat C, Menard JF, Fessard C 1993 Caffeine decreases glial cell number and increases hyaluronan secretion in newborn rat brain cultures. Pediatr Res 34:716-719
10. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE 1999 Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83-133
11. Clancy B, Darlington RB, Finlay BL 2001 Translating developmental time across mammalian species. Neuroscience 105:7-17
12. El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois J 2000 SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor. Eur J Pharmacol 401:63-77
13. Kuzmin A, Johansson B, Gimenez L, Ogren SO, Fredholm BB 2006 Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice. Eur Neuropsychopharmacol 16:129-136
14. nd edition, Academic press, San Diego, p 67
15. Gressens P, Richelme C, Kadhim HJ, Gadisseux JF, Evrard P 1992 The germinative zone produces the most cortical astrocytes after neuronal migration in the developing mammalian brain. Biol Neonate 61:4-24
16. Parnavelas JG 1999 Glial cell lineages in the rat cerebral cortex. Exp Neurol 156:418-429
17. Gressens P, Muaku SM, Besse L, Nsegbe E, Gallego J, Delpech B, Gaultier C, Evrard P, Ketelslegers JM, Maiter D 1997 Maternal protein restriction early in rat pregnancy alters brain development in the progeny. Brain Res Dev Brain Res 103:21-35
18. Zupan V, Nehlig A, Evrard P, Gressens P 2000 Prenatal blockade of vasoactive intestinal peptide alters cell death and synaptic equipment in the murine neocortex. Pediatr Res 47:53-63
19. Vernadakis A 1996 Glia-neuron intercommunications and synaptic plasticity. Prog Neurobiol 49:185-214
20. Lu B, Yokoyama M, Dreyfus CF, Black IB 1991 NGF gene expression in actively growing brain glia. J Neurosci 11:318-326
21. Murphy SN, Miller RJ 1989 Two distinct quisqualate receptors regulate Ca2-+ homeostasis in hippocampal neurons in vitro. Mol Pharmacol 35:671-680
22. Delaney CL, Brenner M, Messing A 1996 Conditional ablation of cerebellar astrocytes in postnatal transgenic mice. J Neurosci 16:6908-6918
23. Jarvis MF, Williams M 1988 Differences in adenosine A-1 and A-2 receptor density revealed by autoradiography in methylxanthine-sensitive and insensitive mice. Pharmacol Biochem Behav 30:707-714
24. Brambilla R, Cottini L, Fumagalli M, Ceruti S, Abbracchio MP 2003 Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 43:190-194
25. Weaver DR 1993 A2a adenosine receptor gene expression in developing rat brain. Brain Res Mol Brain Res 20:313-327
26. Weaver DR 1996 A1-adenosine receptor gene expression in fetal rat brain. Brain Res Dev Brain Res 94:205-223
27. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB 1992 Adenosine and brain ischemia. Cerebrovasc Brain Metab Rev 4:346-369
28. Aden U, Leverin AL, Hagberg H, Fredholm BB 2001 Adenosine A(1) receptor agonism in the immature rat brain and heart. Eur J Pharmacol 426:185-192
29. Lopes LV, Halldner L, Rebola N, Johansson B, Ledent C, Chen JF, Fredholm BB, Cunha RA 2004 Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice. Br J Pharmacol 141:1006-1014
30. Ciccarelli R, Di Iorio P, Ballerini P, Ambrosini G, Giuliani P, Tiboni GM, Caciagli F 1994 Effects of exogenous ATP and related analogues on the proliferation rate of dissociated primary cultures of rat astrocytes. J Neurosci Res 39:556-566
31. Neary JT, McCarthy M, Kang Y, Zuniga S 1998 Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures. Neurosci Lett 242:159-162
32. Rathbone MP, Middlemiss PJ, Kim JK, Gysbers JW, DeForge SP, Smith RW, Hughes DW 1992 Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells. Neurosci Res 13:1-17
33. Abe K, Saito H 1998 Adenosine stimulates stellation of cultured rat cortical astrocytes. Brain Res 804:63-71
34. Hindley S, Herman MA, Rathbone MP 1994 Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist. J Neurosci Res 38:399-406
35. Comer AM, Perry CM, Figgitt DP 2001 Caffeine citrate: a review of its use in apnoea of prematurity. Paediatr Drugs 3:61-79